Search
for
Sort by
Research 31–60 of 516
- Laser Resurfacing
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Dermatologic Reactions to Targeted Therapy
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous Reactions to Drugs
- Study to compare the efficacy of 50% glycolic acid with 65% trichloroacetic acid in the treatment of atrophic acne scar by CROSS technique
- Atypical Morphological Patterns of Topical Steroid-Modified Dermatophytosis: A Cross-Sectional Study in South Asia
- use of dermoscope to differentiate Pityrosporum folliculitis and Acne vulgaris
- Análise comparativa de 126 pacientes com lúpus discoide: perfil clínico e imunológico dos pacientes com lesões no couro cabeludo
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Acne Necrotica in a Woman With Systemic Lupus Erythematosus and Systemic Sclerosis
- Dermatolojik Problemler ve COVID-19
- Clinico-Epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre: A Cross-Sectional Study
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Acne Syndromes and Mosaicism
- Difficult and rare forms of acne
- The clinical features and histopathologic patterns of folliculotropic mycosis fungoides in a series of 38 cases
- Prophylaxis and Management of Skin Toxicities
- Management of Dermatologic Toxicities
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Outbreak of thallium poisoning among Iraqi patients
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies